Home » Medicine

Newer markers in cancer

31 May 2009

Carcinoma: cytokeratin

Sarcoma: desmin / vimentin

Malignant polycythemia rubra vera: V617F JAK2 mutation

FLT3 mutation predicts prognosis in AML

Chromosome 13 abnormality will indicate poor response to conventional treatment in multiple myeloma

Related Articles

Follow us on facebook

Leave your response!